SPOTLIGHT -
Lexapro (Escitalopram) FOREST
SSRI approved for generalized anxiety disorder
Vfend (Voriconazole) PFIZER
Triazole antifungal approved for treatment of esophageal candidiasis
Prevacid NapraPac (Lansoprazole delayed-release capsules and naproxen tablets kit) TAP
New packaging contains PPI and NSAID
Advair Diskus 250/50 (Fluticasone 250 µg and salmeterol 50 µg inhalation powder)
Novel therapy for COPD
Risperdal (Risperidone) JANSSEN
Atypical antipsychotic receives bipolar indication
Risperdal Consta (Risperidone long-acting injection) Janssen/Alkermes
Antipsychotic administered as 1 injection every 2 weeks
Raptiva (Efalizumab)
Biologic therapy for continuous control of plaque psoriasis
Cialis (Tadalafil) Lilly/ICOS
New PDE5 inhibitor approved for erectile dysfunction
Lexiva (Fosamprenavir) GlaxoSmithKline/Vertex
QD or BID administration without food or water restrictions
Zomig (Zolmitriptan nasal spray) AstraZeneca
Migraine therapy available in a nasal spray formulation
Namenda (Memantine) Forest
First approved treatment for moderate-to-severe Alzheimer's disease
Factive (Gemifloxacin) Genesoft
First antibiotic approved for CAP due to multidrug-resistant S pneumoniae
Abilify (Aripiprazole) Bristol-Myers Squibb/Otsuka
Maintenance therapy for schizophrenia
Seasonale (Levonorgestrel and ethinyl estradiol (0.15 mg/0.03 mg) Barr
First extended-cycle oral contraceptive approved
Cubicin (Daptomycin for injection) Cubist
First approval in a new class of antibiotics
Zyprexa (Olanzapine)
Combination therapy for acute bipolar mania
Levitra (Vardenafil)
Phosphodiesterase inhibitor for the treatment of ED
Lamictal (Lamotrigine)
Antiepileptic approved for long-term maintenance treatment of bipolar disorder
Bexxar (Tositumomab and iodine I 131 tositumomab)
New treatment for non-Hodgkin's lymphoma
Reyataz (Atazanavir)
Protease inhibitor for once-daily administration
Gleevec (Imatinib) Novartis
Approved for pediatric chronic myeloid leukemia
Flumist (intranasal influenza virus vaccine, live)
First nasally delivered flu vaccine approved
Xolair (omalizumab)
First biologic approved for the treatment of allergic asthma
Zymar (Gatifloxacin ophthalmic solution, 0.3%)
Fluoroquinolone approved for bacterial conjunctivitis
Vigamox (Moxifloxacin ophthalmic solution, 0.5%)
Broad-spectrum antibiotic available as ophthalmic solution
Velcade (Bortezomib for injection) Millennium
Multiple myeloma treatment represents new class: proteasome inhibitors
Iressa (Gefitinib) ASTRAZENECA
Treatment for lung cancer patients unresponsive to chemotherapy
Avelox (Moxifloxacin) Bayer
Fluoroquinolone approved for community-acquired pneumonia
Somavert (Pegvisomant for injection) Pharmacia
Growth hormone receptor antagonist to treat acromegaly
Emend (Aprepitant) Merck
First in a new class of anti-emetics